MCK · 10-Q · 2026Q2 · Full report

Net Income and Profitability

MCKESSON CORP · 2026-08-05 · Importance 35 · Surprise 48

Net income attributable to McKesson declined 22% to $614 million from $784 million for the three months ended June 30, 2026. Diluted earnings per share decreased 18% to $5.15 from $6.25, despite diluted weighted-average shares falling 5% to 119.2 million because of share repurchases. Net income attributable to noncontrolling interests increased primarily because of higher ClarusONE joint venture volumes and Core Ventures contributions. Noncontrolling interests also reflected $293 million of Medical-Surgical Solutions charges and $81 million of Core Ventures charges to remeasure redeemable interests.

Key facts

• Operating profit subtotal (before corporate expenses and interest) for the three months ended June 30, 2026: $1,576 million; for the three months ended June 30, 2025: $1,293 million. source
• McKesson recorded income before income taxes for the three months ended June 30, 2026: $1,308 million; for the three months ended June 30, 2025: $1,051 million. source
• Net income for the three months ended June 30, 2026: $1,032 million (total); net income attributable to noncontrolling interests presented as (418) and (47) in table (context shows amounts). source
• Segment operating profit subtotal was $1,576 million for the three months ended June 30, 2026 (consolidated income before taxes $1,308 million). source
• Three months ended June 30, 2026 Operating income: $1,319 million source
• Three months ended June 30, 2026 Income before income taxes: $1,308 million source
• Diluted earnings per common share attributable to McKesson decreased to $5.15 from $6.25 for the three months ended June 30, 2026 compared to the prior year period. source
• Net income attributable to McKesson Corporation for the three months ended June 30, 2026: $614 million; for the three months ended June 30, 2025: $784 million. source